See the video in chapter format here
Learning Objectives
-
- Explain the concept of persistent cardiovascular risk beyond LDL-C lowering
- Describe the role of triglycerides as a marker of cardiovascular risk
- List the key data from trials with omega-3 fatty acids
- Apply the evidence from omega-3 fatty acid trials to clinical practice in primary and secondary prevention
- Identify the clinical practice guidelines pertinent to the use of omega-3 fatty acids in vascular protection
Agenda
| Opening Remarks Dr. Lawrence Leiter |
|
| Persistent Vascular Risk: What is the contribution of triglycerides in this regard? Dr. Lawrence Leiter |
Watch Now |
| Detangling the biological complexity and terminology of omega-3 fatty acids: A primer for clinicians. Dr. Robert Hegeler |
Watch Now |
| Clinical trials of icosapent ethyl (IPE), EPA and DHA on cardiovascular events: What are the learnings? Dr. Deepak Bhatt |
Watch Now |
| What is the relevance of these trials to patients in North America? Dr. Subodh Verma |
Watch Now |
| What are the biological underpinnings of the benefits observed? Dr. Jean-Claude Tardif |
Watch Now |
| Q&A | |
| What are the relevant new guidelines that we should be aware of? Dr. Lawrence Leiter |
Watch Now |
| Case based discussion with audience participation Dr. Grace Chua, Dr. Nandini Gupta, Dr. Eva Lonn |
Watch Now |
| Q&A | |
| Closing Remarks Dr. Subodh Verma |
Faculty
Dr. Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
CO-CHAIR
Endocrinologist,
St. Michael’s Hospital;
Professor of Medicine and Nutritional
Sciences, University of Toronto,
Toronto, ON
Dr. Subodh Verma
MD, PhD, FRCSC, FAHA
CO-CHAIR
Cardiac Surgeon, St. Michael’s Hospital;
Professor of Surgery and Pharmacology &
Toxicology, University of Toronto;
Canada Research Chair in Cardiovascular
Surgery, Toronto, ON
Deepak L. Bhatt
MD, MPH, FACC, FAHA, FSCAI, FESC
Cardiologist, Executive Director of
Interventional Cardiovascular Programs,
Brigham and Women’s Hospital
Heart & Vascular Center;
Professor of Medicine,
Harvard Medical School,
Boston, MA
Grace L. Chua
MD, FRCP(C), FACC
Cardiologist,
MacKenzie Health
Vaughan, ON
Nandini Gupta
MD, FRCPC
Cardiologist
Toronto, ON
Robert A. Hegele
MD, FRCPC, FACP, FAHA, FCAHS
Director, London Regional Genomics Centre;
Distinguished University
Professor of Medicine and Biochemistry,
Western University,
London, ON
Eva M. Lonn
MD, MSc, FRCPC, FACC
Cardiologist and Professor of Medicine,
McMaster University;
Director, Research Ultrasound Laboratory,
Population Health Research Institute,
Hamilton, ON
Jean-Claude Tardif
CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS, OC
Director,
Montreal Heart Institute Research Centre
Scientific Director, Montreal Health Innovations
Coordinating Centre;
Professor of Medicine, Université de Montréal,
Montréal, QC
Video Information
- Credit:No Credit Available
- Post Date:June 15, 2020
- Expiry Date:N/A
